Canada

Canada federalized cannabis under the Cannabis Act 2018 — both medical and recreational. All cannabis activities require a Health Canada Licensed Producer (LP) license. The LP system covers cultivation, processing, analytical testing, sales, and research licenses.

Medical cannabis: registered patients receive cannabis directly from an LP using a medical document from a healthcare provider. Recreational cannabis: sold through provincially regulated retail stores. Both streams require the same LP license — the medical framework predates and is incorporated into the Cannabis Act.

Health Canada LP licensing is a lengthy process — 12–18+ months for new applicants. Pre-application preparation, facility construction, security requirements, SOP development, and personnel background checks are all required before application submission. New market entrants should plan accordingly.

Canada is a major global cannabis exporter. Health Canada GPP certificates are accepted by EU GMP network, MHRA UK, TGA Australia, and IMFA Israel under bilateral arrangements. Health Canada export permits required per shipment. ~10 working day processing time — among the fastest in the world.

While Health Canada federal licensing is uniform, provincial retail and distribution models vary significantly. Ontario uses private retail + OCS wholesale. Quebec uses government retail only (SQDC). Alberta has the most privatized model. Use the provincial selector above to explore specific province details.

Per-shipment export permit via Health Canada CTLS system. Processing: approximately 10 working days for complete applications. One of the fastest processing times globally. LP must have export scope on their license.

Germany BfArM: ~5 weeks. UK Home Office: ~10 working days. Australia TGA+ODC: 4–8 weeks. Israel IMFA: ~2–3 weeks. Total supply chain planning: 6–10 weeks from intent to shipment for established trade lanes.

Health Canada export permit (original), Health Canada GPP certificate, GACP certificate, COA per batch (QP signed for EU export), Airway bill, CBSA export declaration, INCB narcotic export notification (filed by Health Canada).

Primary export points. YYZ for transatlantic routes to EU and UK. YVR for Asia-Pacific routes. GDP-compliant pharmaceutical handling facilities at both airports.

Canada imports very little cannabis given its large domestic industry. Research institutions and some clinical trial operators may import specific strains. Health Canada import permit required. In practice, Canada is overwhelmingly an exporting market.

Canada uses GPP under the Cannabis Regulations — the standard is functionally identical to EU-GMP (Health Canada is a PIC/S founding member). All LP licensees must comply with GPP. Health Canada conducts regular compliance inspections.

Health Canada GPP certificates are accepted by MHRA (UK), TGA (Australia), IMFA (Israel), and the EU GMP network under bilateral recognition. For EU markets requiring EU-GMP Part I specifically (e.g. Germany, Netherlands), Canadian LPs typically work with an EU-licensed finisher or obtain an EEA authority EU-GMP certificate.

Some Canadian LPs have obtained EU-GMP Part I certification from EEA authorities (ANSM, IMB) to enable direct finished product import into Germany and Netherlands. This is a growing trend among the larger Canadian exporters. Without Part I, Canadian bulk supply to an EU-licensed finisher is the standard pathway.

All Canadian cannabis must be tracked via Health Canada's CTLS from seed to sale. CTLS provides full chain of custody documentation which supports GMP batch record requirements.

Canadian LPs comply with GPP for cultivation as a condition of their license. GPP includes GACP-equivalent requirements. Health Canada conducts cultivation compliance inspections annually.

EU-importing countries (Germany BfArM, Netherlands CCBM, Czech SÚKL) require EU GACP or WHO GACP certificate from an ISO 17065-accredited body. Canadian LPs exporting to EU must obtain third-party GACP certification even though Health Canada GPP is equivalent.

GACP certificates 1–3 years. Plan renewal audits well before expiry — certificate lapses have disrupted Canadian LP export supply chains.

CTLS tracking covers cultivation lot traceability which supports GACP documentation requirements. Variety and genetic records maintained in CTLS.